GNX-865
GNX-865 is a mitochondrial permeability transition pore (mPTP) inhibitor that protects against ischemia-reperfusion injury in vivo[1].
Product Specifications
CAS Number
1223568-82-8
UNSPSC
12352005
Target
Mitochondrial Metabolism
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/gnx-865.html
Purity
98.09
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
O=C(/C=C/C1=CC=C(C(O)=C1)OC)NC2=CC=CC(Cl)=C2
Molecular Formula
C16H14ClNO3
Molecular Weight
303.74
References & Citations
[1]Fancelli D, et al. Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo. J Med Chem. 2014 Jun 26;57 (12) :5333-47.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941037-100 1x 100 µL
CD44 Standard (DF1485), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
KN211740 1 Kit
PDGF Receptor alpha (PDGFRA) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
BNC881574-100 1x 100 µL
HIF1 alpha (Hypoxia-Inducible Factor 1-alpha) (ESEE122), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details